Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Biopharmaceutical Manufacturing

Product Image
Product Description

Process development, custom manufacturing and innovative purification systems.

We offer you a unique combination of services and advanced technologies for purifying your biopharmaceuticals, from laboratory to industrial scale:

• Bioprocess development: upstream and downstream processing, fill & finish
• Outsourcing solutions: contract manufacturing services, from master cell bank to the commercial released drug product, aseptic formulation and fill & finish
• Insourcing solutions: chromatography and membrane filtration technologies, from lab to industrial scale

Solutions for Biologics Manufacturing

Shorten Time-to-Market:

The biopharmaceutical industry’s objective is to bring new biomolecules to clinical trial more quickly and, therefore, reduce time-to-market. Our process expertise enables us to reduce upstream and downstream bioprocessing development lead-times using advanced methodologies, including where applicable proprietary computer modeling tools.

Regulatory Compliance:
The biopharmaceutical industry cannot compromise when it comes to quality and patient safety. Our solutions comply with all regulatory and quality requirements. Our solutions ensure the highest quality and safety levels while optimizing purity and yield, adhering to the FDA PAT (Process Analytical Technologies) guidelines.

We have built and run our own bioproduction facilities and can bring pragmatic expertise to all disciplines including facility design, process design and development, as well as regulatory and quality requirements.

Increased Production Capacities:
With higher titres, tougher competition and increasingly stringent quality and regulatory requirements, the challenge is to align the efficiency of downstream processing to upstream titres. Our batch and continuous DSP solutions offer unique features that help develop the optimum bioprocess to match your upstream process performance.

Solutions Toward Lean Manufacturing
At Novasep , we can provide solutions for the lean manufacturing of your biopharmaceutical. Through innovative and unique products, all components of lean manufacturing are observed! Interested to learn more, please click here!

Offering for Biopharmaceutical Production and Purification


biopharma-needs.gif
Types of biologics produced with Novasep services


We provide bioprocess development and contract manufacturing services for most types of biologics, from pre-clinical supply to commercial manufacturing.

We combine the complementary talents of chemical and process engineers as well as chemists and biologists to offer our expertise in custom manufacturing services to meet your expectations.  We can produce your development cell bank with several types of cell lines (see upstream biomanufacturing services). We can develop and optimize your cell line  as well as produce your biologics from clinical batches for clinical trials up to phase III with our contract biomanufacturing services.

We provide formulation and fill & finish services to offer a complete solution for your biologics production as well as complete logistic management.

We own a unique palette of DSP technologies (preparative LPLC, MPLC, HPLC, SMCC, filtration solutions) developed for biologics manufacturing.

We provide in-sourcing solutions including innovative and user-friendly biochromatography solutions (Prochrom® Biochromatography columns and Prochrom® Hipersep low pressure chromatography equipment, silica-based protein A media and Prochrom® BioSC multicolumn chromatography systems) and Tangential Flow Filtration (TFF) solutions (TangenX polymeric membranes and Kerasep® Bio mineral membranes, reusable and Sius™ single-use cassettes, TFF systems) for biologics manufacturing.

Product Biopharmaceutical Manufacturing
Company Novasep Inc
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Novasep Inc
82, Boulevard de la Moselle Site Eiffel BP 50 54340 Pompey FRANCE

Tel: + 33 383 49 71 30
Fax: + 33 383 49 71 49
Email: novasep@novasep.com



Scientific News
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!